IP Verse

Sanofi competitive analysis

Latest publications and patents of Sanofi New

Explore the latest publications and patents granted to Sanofi, showcasing their recent innovations and technological advancements.

Last updated on: Sep 28, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Sanofi
EP4571274	Aug 20, 2025	Sensor, Cartridge And Drug Delivery Device	Pending
EP4069338	Aug 20, 2025	Dosing Mechanism With Rotational End Stop Mechanism For Terminating Dose Dispense	Granted
EP3731902	Aug 20, 2025	Data Collection Apparatus For Attachment To An Injection Device	Granted
EP3380134	Aug 20, 2025	Medicament Injection Device	Granted
EP4593960	Aug 6, 2025	Anti-Cd28 Antibodies	Pending
EP4556038	Aug 6, 2025	Autoinjector	Pending
EP4593035	Jul 30, 2025	Predicting Disease Severity	Pending
EP4593021	Jul 30, 2025	Augmenting Real World Patient Data To Include Proxy Endpoint Data	Pending
EP4591905	Jul 30, 2025	Electronic Add-On Module And Assembly Of An Electronic Add-On Module And A Drug Delivery Device	Pending
EP4434562	Jul 30, 2025	Medicament Delivery Device And Actuation Mechanism For A Drug Delivery Device	Pending

Latest oppositions filed by Sanofi

Explore patent oppositions filed by Sanofi against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3728328	Bispecific Antigen Binding Construct	ARGENX BVBA	Jul 23, 2025
EP4226941	Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna	GLAXOSMITHKLINE	Jul 22, 2025
EP3853305	High-Purity Peg Lipids And Uses Thereof	MODERNA	Jun 24, 2025
EP3678654	Pneumococcal Polysaccharides And Their Use In Immunogenic Polysaccharide-Carrier Protein Conjugates	MERCK SHARP & DOHME	Mar 18, 2025
EP3668568	Dosage Measurement Module On Injection Pen	ELI LILLY	Mar 7, 2025
EP3981437	Nucleic Acid Vaccines	MODERNA	Mar 3, 2025
EP4023249	Nucleic Acid Vaccines	MODERNA	Mar 3, 2025
EP4108671	Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof	MODERNA	Feb 28, 2025
EP4017557	Methods And Apparatus For Aspects Of A Dose Detection System	ELI LILLY	Nov 4, 2024
EP3134120	Compositions And Methods For Treating Cytokine-Related Disorders	THE CHILDRENS HOSPITAL OF PHILADELPHIA	Oct 23, 2024

Latest patents of Sanofi opposed by its competitors

Explore Sanofi's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP2571517	Oct 16, 2024	Long - Acting Formulations Of Insulins	1
EP4056212	Oct 9, 2024	Autoinjector	1
EP3506931	Jul 31, 2024	Methods For Preventing Or Treating Allergy By Administering An Il-4R Antagonist	4
EP3889181	Apr 24, 2024	Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist	7
EP3740267	Feb 28, 2024	Packaging Container	1
EP3110848	Feb 14, 2024	Methods For Treating Skin Infection By Administering An Il-4R Antagonist	5
EP3515465	Feb 7, 2024	Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R Inhibitor	7
EP3973987	Jan 10, 2024	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	6
EP2788050	Nov 29, 2023	Syringe Carrier	1
EP4011915	Nov 15, 2023	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	6

Latest PTAB cases involving Sanofi

Discover the latest PTAB cases involving Sanofi, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 4, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Sanofi
IPR2019-01658	Oct 7, 2019	MYLAN PHARMACEUTICALS	SANOFI AVENTIS DEUTSCHLAND	Institution Denied
IPR2019-01022	May 2, 2019	PFIZER	SANOFI AVENTIS DEUTSCHLAND	Terminated-Other
IPR2019-00979	May 2, 2019	PFIZER	SANOFI AVENTIS DEUTSCHLAND	Final Written Decision
IPR2019-00982	May 2, 2019	PFIZER	SANOFI AVENTIS DEUTSCHLAND	Terminated-Other
IPR2019-00981	May 2, 2019	PFIZER	SANOFI AVENTIS DEUTSCHLAND	Terminated-Other
IPR2019-00980	May 2, 2019	PFIZER	SANOFI AVENTIS DEUTSCHLAND	Terminated-Other
IPR2019-00987	May 2, 2019	PFIZER	SANOFI AVENTIS DEUTSCHLAND	Terminated-Other
IPR2019-00978	May 2, 2019	PFIZER	SANOFI AVENTIS DEUTSCHLAND	Terminated-Other
IPR2019-00977	May 2, 2019	PFIZER	SANOFI AVENTIS DEUTSCHLAND	Terminated-Other
IPR2019-01023	May 2, 2019	PFIZER	SANOFI AVENTIS DEUTSCHLAND	Terminated-Other

Peer Comparison New

IP litigation analysis comparing Sanofi with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
SANOFI	59	23	-	-	Highly Aggressive
CUREVAC	-	62	-	1	Non-Active
GLAXOSMITHKLINE	29	112	8	12	Defensive
MODERNA	5	75	4	2	Defensive